Literature DB >> 10854106

Reproductive and menstrual history of females with fragile X expansions.

A Murray1, S Ennis, F MacSwiney, J Webb, N E Morton.   

Abstract

FRAXA premutations have been associated with premature ovarian failure (POF) or menopause before the age of 40. We have studied women in families ascertained because of a mentally retarded full mutation relative and determined their age of menopause, serum hormone levels in premenopausal individuals and the outcome of any pregnancies. Survival analysis was used as a measure of menopause and demonstrated a significant decrease in age of menopause in premutation carriers compared with their full mutation carrier and normal relatives. Serum FSH was also raised in premutation carriers, although oestradiol, inhibin A and inhibin B were not significantly different. However, we did not find an excess of dizygous twins or pregnancy loss/trisomies, both of which are associated with aging ovaries. Thus premutation carriers as a group have an earlier menopause and raised serum FSH but do not appear to manifest other features of an aging ovary.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10854106      PMCID: PMC3725540          DOI: 10.1038/sj.ejhg.5200451

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  18 in total

1.  Instability of a 550-base pair DNA segment and abnormal methylation in fragile X syndrome.

Authors:  I Oberlé; F Rousseau; D Heitz; C Kretz; D Devys; A Hanauer; J Boué; M F Bertheas; J L Mandel
Journal:  Science       Date:  1991-05-24       Impact factor: 47.728

2.  Population screening at the FRAXA and FRAXE loci: molecular analyses of boys with learning difficulties and their mothers.

Authors:  A Murray; S Youings; N Dennis; L Latsky; P Linehan; N McKechnie; J Macpherson; M Pound; P Jacobs
Journal:  Hum Mol Genet       Date:  1996-06       Impact factor: 6.150

3.  The female and the fragile X. A study of 144 obligate female carriers.

Authors:  J P Fryns
Journal:  Am J Med Genet       Date:  1986 Jan-Feb

4.  Quantitative comparison of FMR1 gene expression in normal and premutation alleles.

Authors:  Y Feng; L Lakkis; D Devys; S T Warren
Journal:  Am J Hum Genet       Date:  1995-01       Impact factor: 11.025

5.  Dizygous twinning and premature menopause in fragile X syndrome.

Authors:  G Turner; H Robinson; S Wake; N Martin
Journal:  Lancet       Date:  1994-11-26       Impact factor: 79.321

6.  Obstetrical and gynecological complications in fragile X carriers: a multicenter study.

Authors:  C E Schwartz; J Dean; P N Howard-Peebles; M Bugge; M Mikkelsen; N Tommerup; C Hull; R Hagerman; J J Holden; R E Stevenson
Journal:  Am J Med Genet       Date:  1994-07-15

7.  Detection of dimeric inhibin throughout the human menstrual cycle by two-site enzyme immunoassay.

Authors:  N P Groome; P J Illingworth; M O'Brien; I Cooke; T S Ganesan; D T Baird; A S McNeilly
Journal:  Clin Endocrinol (Oxf)       Date:  1994-06       Impact factor: 3.478

8.  Examination of factors that influence the expansion of the fragile X mutation in a sample of conceptuses from known carrier females.

Authors:  S L Sherman; K L Meadows; A E Ashley
Journal:  Am J Med Genet       Date:  1996-08-09

Review 9.  Trinucleotide repeat expansion and human disease.

Authors:  C T Ashley; S T Warren
Journal:  Annu Rev Genet       Date:  1995       Impact factor: 16.830

10.  Confirmation of early menopause in fragile X carriers.

Authors:  M W Partington; D Y Moore; G M Turner
Journal:  Am J Med Genet       Date:  1996-08-09
View more
  31 in total

1.  No evidence for parent of origin influencing premature ovarian failure in fragile X premutation carriers.

Authors:  A Murray; S Ennis; N Morton
Journal:  Am J Hum Genet       Date:  2000-07       Impact factor: 11.025

2.  Trisomic pregnancy and intermediate CGG repeat length at the FMR1 locus.

Authors:  J Kline; A Kinney; S Brown; B Levin; K Oppenheimer; D Warburton
Journal:  Hum Reprod       Date:  2012-04-06       Impact factor: 6.918

3.  Intra-individual stability over time of standardized anti-Mullerian hormone in FMR1 premutation carriers.

Authors:  M A Spath; T B Feuth; E G Allen; A P T Smits; H G Yntema; A Geurts van Kessel; D D M Braat; S L Sherman; C M G Thomas
Journal:  Hum Reprod       Date:  2011-05-15       Impact factor: 6.918

4.  Nonlinear association between CGG repeat number and age of menopause in FMR1 premutation carriers.

Authors:  Sarah Ennis; Daniel Ward; Anna Murray
Journal:  Eur J Hum Genet       Date:  2006-02       Impact factor: 4.246

5.  Genetic counseling for fragile x syndrome: updated recommendations of the national society of genetic counselors.

Authors:  Allyn McConkie-Rosell; Brenda Finucane; Amy Cronister; Liane Abrams; Robin L Bennett; Barbara J Pettersen
Journal:  J Genet Couns       Date:  2005-08       Impact factor: 2.537

Review 6.  Implications of the FMR1 Premutation for Children, Adolescents, Adults, and Their Families.

Authors:  Anne Wheeler; Melissa Raspa; Randi Hagerman; Marsha Mailick; Catharine Riley
Journal:  Pediatrics       Date:  2017-06       Impact factor: 7.124

7.  FMR1 repeat sizes in the gray zone and high end of the normal range are associated with premature ovarian failure.

Authors:  Karla L Bretherick; Margo R Fluker; Wendy P Robinson
Journal:  Hum Genet       Date:  2005-06-02       Impact factor: 4.132

8.  Psychological symptoms correlate with reduced hippocampal volume in fragile X premutation carriers.

Authors:  P E Adams; J S Adams; D V Nguyen; D Hessl; J A Brunberg; F Tassone; W Zhang; K Koldewyn; S M Rivera; J Grigsby; L Zhang; C Decarli; P J Hagerman; R J Hagerman
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2010-04-05       Impact factor: 3.568

9.  A novel FMR1 PCR method for the routine detection of low abundance expanded alleles and full mutations in fragile X syndrome.

Authors:  Stela Filipovic-Sadic; Sachin Sah; Liangjing Chen; Julie Krosting; Edward Sekinger; Wenting Zhang; Paul J Hagerman; Timothy T Stenzel; Andrew G Hadd; Gary J Latham; Flora Tassone
Journal:  Clin Chem       Date:  2010-01-07       Impact factor: 8.327

10.  Fragile X premutation RNA is sufficient to cause primary ovarian insufficiency in mice.

Authors:  Cuiling Lu; Li Lin; Huiping Tan; Hao Wu; Stephanie L Sherman; Fei Gao; Peng Jin; Dahua Chen
Journal:  Hum Mol Genet       Date:  2012-08-21       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.